Intravenous pantoprazole as an adjuvant therapy following successful endoscopic treatment for peptic ulcer bleeding

Canadian Journal of Gastroenterology

Volumn 23, Issue 4, 2009, Pages 287-299

  Wang, Jun ^a   Yang, Kehu ^a   Ma, Bin ^a   Tian, Jinhui ^a   Liu, Yali ^a   Bai, Zhenggang ^a   Jiang, Lei ^a   Sun, Shaoliang ^a   Li, Jun ^a   Liu, Ruifeng ^a   Hao, Xiangyong ^a   He, Xiaodong ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Endoscopic treatment; Pantoprazole; Peptic ulcer bleeding

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PANTOPRAZOLE; PLACEBO; RANITIDINE; SOMATOSTATIN;

ADJUVANT THERAPY; ARTICLE; BLOOD TRANSFUSION; BOLUS INJECTION; CLINICAL TRIAL; COCHRANE LIBRARY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; EMBASE; ENDOSCOPIC THERAPY; GASTROINTESTINAL SURGERY; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; MEDLINE; META ANALYSIS; MORTALITY; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 65649128159     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/191706     Document Type: Article

References (36)

1. Saltzman JR, Zawacki JK. Therapy for bleeding peptic ulcers, N Engl J Med 1997;336:1091-3.
2. Selby NM, Kubba AK, Hawkey CJ, Acid suppression in peptic ulcer haemorrhage: A 'meta-analysis'. Aliment Pharmacol Ther 2000;14:1119-26.
3. Higham J, Kang JY, Majeed A. Recent trends in admissions and mortality due to peptic ulcer in England: Increasing frequency of haemorrhage among older subjects. Gut 2002;50:460-4.
4. Paimela H, Paimela L, Myllykangas-Luosujärvi R, et al. Current features of peptic ulcer disease in - Finland: Incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years. Scand J Gastroenterol 2002;37:399-403.
5. van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper Gl bleeding: Did anything chang? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003;98:1494-9.
6. Patchett SE, O'Donoghue DP. Pharmacological manipulation of gastric juice: Thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage. Gut 1995;36:358-62.
7. Green FW Jr, Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage, Gastroenterology 1918;74:38-4.
8. Patchett SE, Enright H, Afdhal N, et al. Clot lysis by gastric juice: An in vitro study. Gut 1989;30:1704-7.
9. Chaimoff C, Creter D, Djaldetti M. The effect of pH on platelet and coagulation factor activities. Am J Surg 108;136:257-9.
10. Laine L. Multipolar electrocoagulaiton versus injection therapy in the treatment of bleeding peptic ulcers. A prospective, randomized trial. Gastroenterology 1990;99:1303-6.
11. Cook DJ, Guyatt GH, Salena BJ, et al. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhages: A meta-analysis. Gastroenterology 1992;102:139-48.
12. Gralnek IM, Jensen DM. Gornbein J, et al. Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: An analysis of two prospective clinical trials. Am J Gastroenterol 1998;93:2047-56.
13. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27.
14. Avgerinos A, Sgouro S, Viazis N, et al. Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: A prospective, randomized, placebo-controlled trial. Scand J Gastroenterol 2005;40:515-22.
15. Kaviani MJ, Hashemi MR, Kazemifar AR, et al. Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: A prospective, double-blind, randomized, clinical trial. Aliment Pharmacol Ther 2003;17:211-6.
16. Lin HJ, Lo WC, Lee FY, et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998;158:54-8.
17. Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazzole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6.
18. Javid G, Masoodi I, Zargar SA, et al. Omeprazole as adjuvant therapy to endoscopic combination injection sclerotherapy for treating bleeding peptic ulcer. Am J Med 2001;111:280-4.
19. Brunner G, Luna P, Hartmann M, et al. Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med 1996;69:225-31.
20. van Rensburg CJ, Hartmann M, Thorpe A, et al. Intragastric pH during continuous infusion with pantoprazole in patients with bleeding peptic ulcer. Am J Gastroenterol 2003;98:2635-41.
21. Leontiadis GI, Sharma VK, Howden CW. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials. Mayo Clin Proc 2007;82:286-96.
22. Zargar SA, Javid G, Khan BA, et al. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: Prospective randomized controlled trial. J Gastroenterol Hepatol 2006;21:716-21.
23. Hung WK, Li VK, Chung CK, et al. Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers. ANZ J Surg 2007;77:677-81.
24. Hsu PI, Lo GH, Lo CC, et al. Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers. World J Gastroenterol 2004;10:3666-9.
25. Jensen DM, Pace SC, Soffer E, et al. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: A U.S. multicenter randomized, double-blind study. Am J Gastroenterol 2006;101: 1991-9.
26. Tsibouris P, Zintzaras E, Lappas C. High-dose pantoprazole continuous infusion is superior to somatostatin after endoscopic hemostasis in patients with peptic ulcer bleeding. Am J Gastroenterol 2007;102:1192-9.
27. Fried R, Beglinger C, Meier R, et al. Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding. Gut 1999;45:(Abst)Al00.
28. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med 2001;344:1594-602.
29. Sonnenberg GE, Keller U, Perruchoud A, et al. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Gastroenterology 1981;80:526-32.
30. Saruç M, Can M, Küçükmetin N, et al. Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: A pilot study. Med Sci Monit 2003;9:84-7.
31. Berstad A, Holm HA, Kittang E. Experience with antipeptic agents. Scand J Gastroenterol Suppl 1979;55:121-3.
32. Raptis S, Dollinger HC, von Berger L, et al. Effects of somatostatin on gastric secretion and gastrin release in man. Digestion 1975;13:15-26.
33. van Herwaarden MA, Samsom M, van Nispen CH, et al. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine. Aliment Pharmacol Ther 1999;13:731-40.
34. Lam SK, Hasan M, Sircus W, et al. Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 1980;21:324-8.
35. Caraco Y, Lagerstrom PO, Wood AJ. Ethnic and genetic determinants of omeprazole disposition and effect. Clin Pharmacol Ther 1996;60:157-67.
36. Caraco Y, Wilkinson GR, Wood AJ. Difference between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazole. Clin Pharmacol Ther 1996;60:396-404.